. Author manuscript; available in PMC: 2009 Jul 1.

Published in final edited form as: Am Heart J. 2008 Mar 6;156(1):106–111. doi: 10.1016/j.ahj.2007.12.035

Table 2.

Adjusted Mean Differences in CRP by Duration of Aspirin Exposure and Statin Use^*

Drug	No Statin		Statin Use
	Difference in mean log CRP	P-value	Difference in mean log CRP	P-value

No regular ASA use		P_none-short = 0.99		P_none-short = 0.08
No regular ASA use	Reference Group	P_none-long = 0.25	Reference Group	P_none-long = <0.0001
Short-term ASA use (≤ 5 years)		P_short-long = 0.31		P_short-long = 0.01
Short-term ASA use (≤ 5 years)	0.000		−0.072
Long-term ASA use (> 5 years)	−0.042		−0.189

Adjusted for race, gender, smoking status, body mass index, hypertension, diabetes, previous cardiovascular symptoms or procedures, education, income, and physical activity, shown by regular aspirin use for cardiovascular protection and statin use.